Midatech Pharma PLC (MTP)
| Market Cap | 12.36M |
| Revenue (ttm) | 770,667 |
| Net Income (ttm) | -7.28M |
| Shares Out | 19.74M |
| EPS (ttm) | -0.43 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 22,095 |
| Open | 0.649 |
| Previous Close | 0.610 |
| Day's Range | 0.570 - 0.649 |
| 52-Week Range | 0.380 - 3.610 |
| Beta | 1.54 |
| Analysts | Sell |
| Price Target | n/a |
| Earnings Date | Apr 29, 2022 |
About MTP
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-actin...
Financial Performance
In 2021, MTP's revenue was 578,000, an increase of 68.51% compared to the previous year's 343,000. Losses were -5.46 million, -75.39% less than in 2020.
Financial numbers in millions GBPFinancial StatementsNews
Midatech Pharma PLC Announces Posting of Annual Report & Notice of AGM
ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 24, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines...
Midatech Pharma PLC Announces Results for the Year Ended 31 December 2021
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 26, 2022 / Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, anno...
Midatech Pharma PLC Announces Receipt of NASDAQ Notice
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 14, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicine...
Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule
ABINGDON, UK / ACCESSWIRE / March 9, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is plea...
Midatech Pharma PLC Announces Appointment of Nominated and Financial Adviser
ABINGDON, UK / ACCESSWIRE / March 8, 2022 / Midatech Pharma PLC (AIM:MTPH; NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicine, is pleas...
Midatech Pharma PLC Announces Extension of Janssen collaboration re Q-Sphera
Midatech announces extension of R&D collaboration with Janssen focused on Q-Sphera technology ABINGDON, UK / ACCESSWIRE / January 17, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery t...
Midatech Pharma PLC Announces IND Application for MTX110 Study in GBM Effective
Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON, OXFORDSHIRE / ACCESSWIRE / December 13, 2021 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:...
Midatech Pharma PLC Announces Notice of Interim Results
ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 6, 2021 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medic...
Midatech Pharma PLC Announces Appointment of Chief Scientific Officer
Midatech Pharma PLC ('Midatech' or the 'Company') Midatech Strengthens Management Team with Appointment of Dr. Dmitry Zamoryakhin as Chief Scientific Officer ABINGDON, OXFORDSHIRE / ACCESSWIRE / July 12...
Midatech Pharma Secures £10M In Equity To Fund Product Development
Midatech Pharma plc (NASDAQ: MTP) has raised £10 million from equity placing to fund its product development pipeline. Approximately 35 million new shares in the Company were issued at 28.5p each, a 12%...
MTP Stock: The Big Midatech Pharma News That Has Shares Rocketing Today
Shares of MTP stock are skyrocketing on Thursday following news of positive results from a portion of Midatech Pharma's technology. The post MTP Stock: The Big Midatech Pharma News That Has Shares Rocke...
Midatech Pharma Stock Jumps After Breakthrough Data On Encapsulation Of Biologic Using Q-Sphera
Midatech Pharma PLC (NASDAQ: MTP) has announced a breakthrough in vitro data utilizing Q-Sphera technology and progress across multiple other programs. The technology showed potential to formulate prote...
Midatech Pharma PLC Announces Breakthrough Data Using Q-Sphera Technology
Breakthrough data on the successful encapsulation of a biologic using Q-Sphera technology Significant progress across multiple other R&D programmes ABINGDON, OXFORDSHIRE/ ACCESSWIRE / June 17, 2021 / Mi...
Midatech Pharma PLC Announces Investor Webinar Scheduled for 17 June 2021
ABINGDON, UK / ACCESSWIRE / June 9, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, will b...
Midatech Pharma PLC Announces Results for the Year Ended 31 December 2020
Preliminary Results for the Year Ended 31 December 2020 ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 30, 2021 / Midatech Pharma PLC (AIM:MTPH.L); (NASDAQ:MTP), a drug delivery technology company focused o...
Midatech Pharma PLC Announces MTX110 Update & Headline Results for 2020
Non-binding Heads of Terms for Co-development of MTX110; Unaudited Headline Results for the Year Ended 31 December 2020 ABINGDON, UK / ACCESSWIRE / March 25, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASD...
Midatech Pharma News: Why MTP Stock Is Surging 10% Today
Midatech Pharma (MTP) news for Monday includes positive results from a Phase I study of a DIPG treatment boosting MTP stock higher. The post Midatech Pharma News: Why MTP Stock Is Surging 10% Today appe...
Midatech Pharma News: Why MTP Stock Is Soaring 56% Today
Midatech Pharma (MTP) news for Friday includes talk from the company about reselling roughly 12.7 million shares pushing MTP stock higher. The post Midatech Pharma News: Why MTP Stock Is Soaring 56% Tod...
Midatech Pharma News: Why MTP Stock Is Skyrocketing 154% Today
Midatech Pharma (MTP) news for Tuesday concerning a collaboration deal involving the Q-Sphera platform has MTP stock taking off. The post Midatech Pharma News: Why MTP Stock Is Skyrocketing 154% Today a...
Midatech Pharma News: MTP Stock Rockets on Diabetes Vaccine Results
A stronger diabetes vaccine may be what the doctor will order soon as Midatech Pharma's clinical trial were "positive." MTP stock is up.
Midatech Pharma Rallies On Positive MTX102 Results
Midatech Pharma PLC-ADR (NASDAQ: MTP) shares were trading higher Friday after the company announced positive results from a first-in-human study of its MTX102 immuno-tolerizing vaccine product candidate...
Midatech's stock rockets on heavy volume after positive results from diabetes treatment study
The U.S.-listed shares of Midatech Pharma PLC rocketed 113% on very heavy volume in premarket trading Friday.